RNA Binding Proteins in MLL-rearranged Leukemia
Overview
Authors
Affiliations
RNA binding proteins (RBPs) have recently emerged as important post-transcriptional gene expression regulators in both normal development and disease. RBPs influence the fate of mRNAs through multiple mechanisms of action such as RNA modifications, alternative splicing, and miR-mediated regulation. This complex and, often, combinatorial regulation by RBPs critically impacts the expression of oncogenic transcripts and, thus, the activation of pathways that drive oncogenesis. Here, we focus on the major features of RBPs, their mechanisms of action, and discuss the current progress in investigating the function of important RBPs in MLL-rearranged leukemia.
Three-dimensional chromatin landscapes in MLLr AML.
Sui P, Wang Z, Zhang P, Pan F Exp Hematol Oncol. 2024; 13(1):56.
PMID: 38778427 PMC: 11110396. DOI: 10.1186/s40164-024-00523-5.
Inflammation as a driver of hematological malignancies.
Saluja S, Bansal I, Bhardwaj R, Beg M, Palanichamy J Front Oncol. 2024; 14:1347402.
PMID: 38571491 PMC: 10987768. DOI: 10.3389/fonc.2024.1347402.
Chen T, Huang H, Zhu S, Chen X, Pu K, Wang D Exp Hematol Oncol. 2024; 13(1):18.
PMID: 38374003 PMC: 10877858. DOI: 10.1186/s40164-024-00488-5.
Alternative splicing and related RNA binding proteins in human health and disease.
Tao Y, Zhang Q, Wang H, Yang X, Mu H Signal Transduct Target Ther. 2024; 9(1):26.
PMID: 38302461 PMC: 10835012. DOI: 10.1038/s41392-024-01734-2.
Zhao P, Xia L, Chen D, Xu W, Guo H, Xu Y Exp Hematol Oncol. 2024; 13(1):8.
PMID: 38268051 PMC: 10807064. DOI: 10.1186/s40164-024-00477-8.